Discussion IBD showed an increasing trend of incidence worldwide, and current therapies mainly consist of the chronic administration of immunosuppressive drugs [ 19 ].
← all excerpts
N-Palmitoyl-D-Glucosamine Inhibits TLR-4/NLRP3 and Improves DNBS-Induced Colon Inflammation through a PPAR-α-Dependent Mechanism.
1
—
—